Genetic Signatures Limited [ASX:GSS] share price and news 2022

Company Description

Genetic Signatures Limited (GSS) is a molecular diagnostics (MDx) company focused on the development and commercialisation of its proprietary platform technology, 3Base. The company deals in the the research and commercialisation of identifying individual genetic signatures to aid in the diagnosis of infectious diseases and the sale of associated products into the diagnostic and research marketplaces.

Genetic Signatures Limited belongs to Health Care sector and under industry of Life Sciences Tools & Services. You can get more information about this company via their website: http://www.geneticsignatures.com.

This a small cap company with market cap of 224 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is greater than both sector and market. while On the other hand, Company Earning is greater than both sector and market.

Earnings PE PB PE growth
Company 3 76.4 4.87 1.42
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how gss dividend grows in the recent years.

No data